Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVP-786 as Adjunctive Therapy in Major Depressive Disorder
NCT02153502Phase 2Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Jul 2014
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of deudextromethorphan in major depressive disorder (MDD), sponsored by Otsuka Pharmaceutical Development & Commercialization. Started Jul 2014; status: completed.
02
Drugs
deudextromethorphan
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02153502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02153502.